Roche Nimblegen has announced that Seoul-based genomic services provider Macrogen has joined the Roche Nimblegen Certified Service Provider (CSP) programme.
Macrogen has been certified to process customer samples for Nimblegen Comparative Genomic Hybridization/Copy Number Variation (CGH/CNV) services in its lab in Seoul.
As a CSP, Macrogen will process gDNA samples for CGH/CNV using the complete Nimblegen array CGH workflow, which includes the high-resolution Nimblegen MS 200 microarray scanner.
Macrogen finished the Korea Centers for Disease Control and Prevention (KCDC) CNV projects using Roche Nimblegen aCGH microarrays in 2009.
The KCDC CNV project was a two-phase study including large-scale characterisation of CNVs in Korean populations and analysis of common CNVs in genome-wide association studies for 6,000 Korean individuals.
CGH is a tool that allows the detection of chromosomal abnormalities, copy number variations and specific break-points at much higher resolution over conventional methods, according to Roche.
The genome-wide and disease associated region focused research that this technology provides on these types of chromosomal phenomenon has the potential to bring advances into the development of personalised healthcare options in the future.
